Item 8.01. Other Events.
On November 1, 2019, DTE Energy Company (the “Company”) issued and sold 26,000,000 Equity Units, initially consisting of Corporate Units (the “Corporate Units”), for an aggregate stated amount of $1,300,000,000, as more fully described below, pursuant to an Underwriting Agreement, dated October 29, 2019, between the Company and the several Underwriters named in Schedule I thereto (the “Units Underwriting Agreement”), for whom Barclays Capital Inc. acted as representative.
Also on November 1, 2019, the Company issued 2,760,000 shares of common stock (the “Common Stock”), pursuant to an Underwriting Agreement, dated October 29, 2019, between the Company and the several Underwriters named in Schedule I thereto (the “Common Stock Underwriting Agreement”), for whom Barclays Capital Inc. acted as representative.
The Common Stock and the Corporate Units have been issued pursuant to the Company’s Registration Statement on Form S-3 (Registration No. 333-230656) (the “Registration Statement”), and the Prospectus Supplements each dated October 29, 2019. Copies of the Units Underwriting Agreement, the Common Stock Underwriting Agreement and opinions related to the Corporate Units are attached hereto as exhibits and are expressly incorporated by reference herein and into the Registration Statement. The foregoing descriptions of the terms of the Units Underwriting Agreement and the Common Stock Underwriting Agreement are qualified in their entirety by reference to the actual terms of the applicable exhibits attached hereto.
Each Corporate Unit has a stated amount of $50 and is comprised of (i) a purchase contract obligating the holder to purchase from the Company for a price in cash of $50, on the purchase contract settlement date, or November 1, 2022, subject to earlier termination or settlement, a certain number of shares of common stock; and (ii) a 1/20, or 5%, undivided beneficial ownership interest in $1,000 principal amount of the Company’s 2019 Series F 2.25% Remarketable Senior Notes due 2025 (the “Remarketable Notes”). Holders of the Corporate Units will be entitled to receive quarterly contract adjustment payments at a rate of 4.00% per year of the stated amount of $50 per Corporate Unit, subject to the Company’s right to defer such payments.
The Remarketable Notes are being issued pursuant to an indenture, dated as of April 9, 2001, between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee (the “Remarketable Note Trustee”), as supplemented by a supplemental indenture, dated as of November 1, 2019 (as supplemented, the “Remarketable Note Indenture”), between the Company and the Remarketable Note Trustee. The Corporate Units are being issued pursuant to a Purchase Contract and Pledge Agreement, dated as of November 1, 2019 (the “Purchase Contract and Pledge Agreement”), between the Company and The Bank of New York Mellon Trust Company, N.A., as purchase contract agent, collateral agent, custodial agent and
securities intermediary. Under the terms of the Purchase Contract and Pledge Agreement, the Remarketable Notes are being pledged as collateral to secure the holders’ obligation to purchase the shares of Common Stock under the related purchase contracts that form a part of the Corporate Units. A holder of Corporate Units, at its option, may elect to create “Treasury Units” by substituting pledged U.S. Treasury securities for any pledged ownership interests in the Remarketable Notes. The Remarketable Notes will be remarketed, subject to certain terms and conditions, prior to the purchase contract settlement date pursuant to the terms of the Purchase Contract and Pledge Agreement and a remarketing agreement to be executed in the future.
Copies of the Purchase Contract and Pledge Agreement and the related Supplemental Indenture, are attached hereto as exhibits and are expressly incorporated by reference herein and into the Registration Statement. The foregoing descriptions are qualified in their entirety by reference to the actual terms of the exhibits attached hereto.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
|
|
|
1.1
|
|
|
|
1.2
|
|
|
|
4.1
|
|
|
|
4.3
|
|
|
|
5.1
|
|
|
|
8.1
|
|
|
|
23.1
|
|
|
|
23.2
|
|